Fredag 27 December | 18:23:42 Europe / Stockholm

Prenumeration

Kalender

Tid*
2025-08-19 07:00 Kvartalsrapport 2025-Q2
2025-05-08 N/A Årsstämma
2025-04-29 07:00 Kvartalsrapport 2025-Q1
2025-02-19 07:00 Bokslutskommuniké 2024
2024-11-26 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-05-21 - X-dag ordinarie utdelning BICO 0.00 SEK
2024-05-20 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-20 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-22 - Kvartalsrapport 2023-Q2
2023-05-10 - X-dag ordinarie utdelning BICO 0.00 SEK
2023-05-09 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-12-14 - Extra Bolagsstämma 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-24 - Kvartalsrapport 2022-Q2
2022-05-18 - Kvartalsrapport 2022-Q1
2022-04-27 - X-dag ordinarie utdelning BICO 0.00 SEK
2022-04-26 - Årsstämma
2022-02-23 - Bokslutskommuniké 2021
2021-11-17 - Extra Bolagsstämma 2021
2021-11-10 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-12 - Kvartalsrapport 2021-Q1
2021-04-27 - X-dag ordinarie utdelning BICO 0.00 SEK
2021-04-26 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-12-18 - X-dag ordinarie utdelning BICO 0.00 SEK
2020-12-17 - Extra Bolagsstämma 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-04-09 - Kvartalsrapport 2020-Q2
2020-01-20 - Kvartalsrapport 2020-Q1
2020-01-10 - Split BICO 1:4
2019-12-19 - X-dag ordinarie utdelning BICO 0.00 SEK
2019-12-18 - Årsstämma
2019-10-24 - Bokslutskommuniké 2019
2019-08-26 - Extra Bolagsstämma 2019
2019-07-11 - Kvartalsrapport 2019-Q3
2019-04-10 - Kvartalsrapport 2019-Q2
2018-12-14 - X-dag ordinarie utdelning BICO 0.00 SEK
2018-12-13 - Årsstämma
2018-10-24 - Bokslutskommuniké 2018
2018-07-11 - Kvartalsrapport 2018-Q3
2018-04-11 - Kvartalsrapport 2018-Q2
2018-01-17 - Kvartalsrapport 2018-Q1
2017-12-15 - X-dag ordinarie utdelning BICO 0.00 SEK

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
BICO Group är verksamma inom medicinteknik. Bolaget är specialiserade inom biokonvergens och tillhandahåller teknik, produkter och tjänster för biologi. Med fokus på applikationsområdena bioprintning, multiomics, cellinjeutveckling och diagnostik utvecklar och marknadsför bolaget teknik som gör det möjligt för forskare att odla celler i 3D-miljöer, genomföra läkemedelsscreening och skriva ut mänskliga vävnader och organ för medicinsk, läkemedels- och kosmetisk industri.
2024-10-09 07:00:00

BICO Group’s major owners have appointed a Nomination Committee and the Annual General Meeting of BICO Group AB will be held on Thursday May 8, 2025.

In accordance with the decision by the Annual General Meeting 2024 when the most recently adopted principles regarding the composition of the nomination committee was made, the Nomination Committee of BICO Group AB shall consist of four members appointed by the largest shareholders. The Chairman of the Board shall not be a member of the Nomination Committee but shall normally be co-opted to the meeting of the Nomination Committee.

The four largest shareholders who wish to participate in the committee are entitled to appoint one member each. In preparation for the 2025 Annual General Meeting the members of the Nomination Committee have been appointed based on the ownership structure as of September 30, 2024, and consists of:

  • Erik Gatenholm, nominated by himself
  • Jens M. Artelt, nominated by Sartorius Lab Holding GmbH
  • Malin Björkmo, nominated by Handelsbanken Fonder (Chairperson of the Nomination Committee)
  • Héctor Martínez, nominated by himself
  • Rolf Classon, Chairman of the Board of BICO Group AB (co-opted)

Shareholders having appointed members to the Nomination Committee represent approximately 51 percent of the voting rights for all shares of BICO Group AB. The Nomination Committee has also appointed Malin Björkmo as Chairperson of the Nomination Committee.

The Nomination Committee will prepare proposals for the Annual General Meeting 2025 regarding election of chairman/woman and other directors of the board, election of auditor, matters regarding fees, election of chairman/woman of the Annual General Meeting and resolution concerning the Nomination Committee.

Shareholders who wish to submit proposals to the Nomination Committee ahead of the Annual General Meeting 2025 are welcome to contact the Nomination Committee by email: ir@bico.com. Please write “To the Nomination Committee” in the subject line or per mail:

BICO Group AB
att. Nomination Committee
Långfilsgatan 9
412 77 Gothenburg
Sweden

Proposals shall be submitted in writing in due time before the Annual General Meeting, no later than January 31, 2025, to ensure that the proposals can be considered by the Nomination Committee.